Business Wire

Additional Analytical Results of the US-Based Phase 2b Clinical Trial of Regenerative Cell Medicine SB623 for the Treatment of Chronic Motor Deficit From Ischemic Stroke, and ...

TOKYO--(BUSINESS WIRE)--SanBio Co., Ltd. (headquarters: Chuo-ku, Tokyo, Representative Director and President: Keita Mori, hereafter “SanBio”) hereby announces that it has obtained new analytical ...
Business Wire

Positive Phase 2 Topaz Trial Extension Data Demonstrate Sizable and Sustained Motor Function Improvement at 24 Months with Apitegromab for Non-Ambulatory Patients with Types 2 ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a Phase 3, clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a ...
IFLScience

Motor Neurone Disease Drug Shows Success In Clinical Trials

IFLScience needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time.
Scientific American

A Proposed Electro-Motor Trial

Scientific American is part of Springer Nature, which owns or has commercial relations with thousands of scientific publications (many of them can be found at www ...
The New York Times

MOTOR TRIAL A FIASCO; Only One Entry for Gordon Bennett Race Attempts to Run. PROTEST LIKELY TO FOLLOW Percy Owen Refuses to Sign Liability Release and Withdraws the Bullet ...

TimesMachine is an exclusive benefit for home delivery and digital subscribers. About the Archive This is a digitized version of an article from The Times’s print archive, before the start of online ...